መነሻ › የእንቁላል ካንሰር › ሚሺጋን › Detroit
በDetroit፣ MI ለየእንቁላል ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች
ለየእንቁላል ካንሰር የሚደረጉ 26 ጥናቶች በDetroit እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
The Vanguard Study: Testing a New Way to Screen for Cancer
ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
- Henry Ford Hospital, Detroit
- Henry Ford Medical Center - Detroit Northwest, Detroit
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
- Henry Ford Hospital, Detroit
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Research Site, Detroit
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Henry Ford Health, Detroit
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Karmanos Cancer Institute, Detroit
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Site 0101 - Barbara Ann Karmanos Cancer Institute, Detroit
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Karmanos Cancer Institute, Detroit
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Karmanos Cancer Institute, Detroit
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Barbara Ann Karmanos Cancer Institute, Detroit
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Karmanos Cancer Institute - Detroit /ID# 277085, Detroit
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Henry Ford Cancer - Detroit, Detroit
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Karmanos Cancer Institute, Detroit
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Karmanos Cancer Institiute, Detroit
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Karmanos Cancer Institute, Detroit
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Karmanos Cancer Institute, Detroit
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Karmanos Cancer Center, Detroit
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Henry Ford Health Saint John Hospital, Detroit
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Karmanos Cancer Institute, Detroit
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Karmanos Cancer Institute, Detroit
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Henry Ford Health Hospital, Detroit
ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Barbara Ann Karmanos Cancer Institute, Detroit
A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Karmanos Cancer Institute - Detroit /ID# 272112, Detroit
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Karmanos Cancer Institute, Detroit
A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Karmanos Cancer Institute, Detroit
A Beta-only IL-2 ImmunoTherapY Study
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Karmanos Cancer Institute, Detroit
BP1001-A in Patients With Advanced or Recurrent Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Karmanos Cancer Institute, Detroit
በሌሎች ከተሞች ለየእንቁላል ካንሰር የሚደረጉ ጥናቶች
- Houston, TX89 ጥናቶች
- New York City, NY69 ጥናቶች
- Boston, MA61 ጥናቶች
- Los Angeles, CA50 ጥናቶች
- Nashville, TN49 ጥናቶች
- Arlington, VA46 ጥናቶች
- Philadelphia, PA44 ጥናቶች
- Columbus, OH39 ጥናቶች
- St. Louis, MO38 ጥናቶች
- Chicago, IL36 ጥናቶች
- San Antonio, TX31 ጥናቶች
- Cleveland, OH30 ጥናቶች
በDetroit ውስጥ ያሉ ሌሎች ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር44 ጥናቶች
- የጡንቻ ካንሰር33 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)29 ጥናቶች
- የኮሎሬክታል ካንሰር26 ጥናቶች
- Metastatic Cancer24 ጥናቶች
- የፕሮስቴት ካንሰር22 ጥናቶች
- የኤንዶሜትሪየም ካንሰር21 ጥናቶች
- የሳንባ ካንሰር20 ጥናቶች
- Multiple Myeloma19 ጥናቶች
- የሆድ ካንሰር16 ጥናቶች
- የራስ እና የአንገት ስኩዋመስ ሴል ካርሲኖማ15 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ14 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።